Amir London, CEO of Israeli biotech Kamada, was interviewed on ILTV Daily about Kamada’s protein purification treatments for lung disease and rabies. Kamada’s Glassia is also being tested for treating Type 1 diabetes, GVHD and the rejection of bone marrow and lung transplants.
Life-saving treatments from Kamada
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.